![Piet Wigerinck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Piet Wigerinck
Directeur/Membre du Conseil chez IPSEN
Fortune : 89 028 $ au 31/05/2024
Postes actifs de Piet Wigerinck
Sociétés | Poste | Début | Fin |
---|---|---|---|
IPSEN | Directeur/Membre du Conseil | 01/05/2018 | - |
Independent Dir/Board Member | 01/05/2018 | - | |
University Hospital Antwerp
![]() University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Directeur/Membre du Conseil | - | - |
miDIAGNOSTICS NV
![]() miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Directeur/Membre du Conseil | - | - |
Independent Dir/Board Member | - | - | |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Directeur/Membre du Conseil | - | - |
Independent Dir/Board Member | - | - | |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Piet Wigerinck
Anciens postes connus de Piet Wigerinck
Sociétés | Poste | Début | Fin |
---|---|---|---|
GALAPAGOS NV | Directeur Technique/Scientifique/R&D | 19/04/2012 | 31/12/2021 |
Corporate Officer/Principal | 01/04/2008 | 19/04/2012 | |
UZA Foundation | Directeur/Membre du Conseil | - | - |
Xinvento BV
![]() Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Fondateur | - | - |
Tibotec-Virco Comm Va | Corporate Officer/Principal | - | - |
░░░░ ░░░░░░░░░ ░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Piet Wigerinck
Katholieke Universiteit Leuven | Doctorate Degree |
Statistiques
Internationale
Belgique | 7 |
Pays-Bas | 3 |
France | 2 |
Opérationnelle
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Sectorielle
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
IPSEN | Health Technology |
GALAPAGOS NV | Health Technology |
Entreprise privées | 8 |
---|---|
University Hospital Antwerp
![]() University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Health Services |
miDIAGNOSTICS NV
![]() miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Commercial Services |
Drug Discovery & Development Solutions Ltd.
![]() Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Drug Discovery & Development Solutions Ltd. engages in the provision of financial services. The company is headquartered in Singapore. | Commercial Services |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Health Technology |
Tibotec-Virco Comm Va | |
Xinvento BV
![]() Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Health Technology |
UZA Foundation |
- Bourse
- Insiders
- Piet Wigerinck
- Expérience